Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms

João Agostinho Machado‐Neto(Universidade de São Paulo), Fabı́ola Traina(Universidade de Ribeirão Preto)

Cell Death and Disease

February 22, 2018

10.1038/s41419-017-0256-4

Cited by 30

Related Papers

BCR‐ABL binds to IRS‐1 and IRS‐1 phosphorylation is inhibited by imatinib in K562 cells

|FEBS Letters|2002|39

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy

|Blood Cancer Journal|2022|29

Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms

|Scientific Reports|2019|22

Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells

|Oncotarget|2015|20

Targeting glioma cells by antineoplastic activity of reversine

|Oncology Letters|2021|13